Articlo
Check my manuscript free

Taylor & Francis

Prepare your manuscript for Systems Biology in Reproductive Medicine.

Review the checklist, choose your article type, and turn your draft into a cleaner submission package.

Checked 2026-08-02
Check readiness freePrepare this manuscript

Article types

Review
Clinical Trial
Research Article
Case Report
Editorial
Letter
Protocol
Methods Article
Lectio
Systematic Review

Readiness requirements

Review the key details below, or download the complete checklist with every stored source-backed requirement.

Abstract length

  • Provide an author-written abstract of no more than 300 words.
  • Use a unstructured abstract.
Show 6 more
  • Case Report: Use a unstructured abstract.
  • Research Article: Use a unstructured abstract.
  • Include the heading, Graphical Abstract: a title in bold, followed by a brief description.
  • Trial registration numbers should be included in the abstract, with full details in the methods section.
  • Case Report: Clinical: Case Reports should be written with the following elements in the following order: Main file: title page (see Checklist below for details) as first page of main file; unstructured Abstract of up to 300 words that reads as one paragraph stating the rationale, hypothesis, results, conclusions, and include a statement regarding any limitations of the study, e.g., small sample size, limited access to data, limitations of research design, lack of generalizability, etc.; graphical abstract (optional), keywords (between 4 and 6 keywords), list of abbreviations (if applicable).
  • There are no strict formatting requirements, but all manuscripts must contain the essential elements needed to evaluate a manuscript: abstract, author affiliation, figures, tables, funder information, references.

Keywords

  • Provide 4-6 keywords chosen by the author.

Reference style

  • Articlo formats your supplied references to the journal's stored style and checks that citations match the reference list; source validity is not verified.
  • For manuscripts submitted in LaTeX format a.bib reference file must be included.
Show 5 more
  • All bibliographic entries must contain a corresponding in-text citation.
  • Readers should be able to interpret the table without reference to the text.
  • If you reply yes, you will be required to provide the DOI, pre-registered DOI, hyperlink, or other persistent identifier associated with the data set(s).
  • The DAS should include the hyperlink, DOI or other persistent identifier associated with the data set(s), or information on how the data can be requested from the authors.
  • A declaration must be included within the submission stating: Confirmation the authors take full responsibility for the integrity of the whole content, including accuracy of references.

Figure and table rules

  • Keep every figure and table numbered, captioned, and cited in the manuscript.
  • Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi for color, at the correct size).
Show 11 more
  • All figures must be created to either fit within the width of a single column (83 mm) or the width of a portrait page (173 mm).
  • Together these summary tables should facilitate the large meta-analyses that are necessary to realize the potential of a Personalized and Precision Reproductive Medicine.
  • Figures should be of sufficient resolution to enable refereeing.
  • Figures should be supplied in one of our preferred file formats: PS, JPEG, GIF, or Microsoft Word (DOC or DOCX).
  • Submit the figure title and caption separate from the figure as indicated above.
  • Submit figure panels as stacked, i.e., A above B, etc. or as a separate file for each panel.
  • Tables should present new information rather than duplicating what is in the text.
  • Tables must be created to either fit within the width of a single column or the width of a portrait page.
  • The Table number and title should appear at the top of the table (in bold).
  • All descriptions or key should be placed under the table.
  • A standardized report of causative and risk factors of infertility with an emphasis of male infertility is required when any of the following data, as outlined in Tables 1 and 2 (Adapted from Eva Traven, Ana Ogrinc & Tanja Kunej (2017) Initiative for standardization of reporting genetics of male infertility, Sys Biol Reprod Med 63:1, 58-66), are submitted for consideration for publication in Systems Biology in Reproductive Medicine.

Funding statement

  • Add or confirm the author-written Funding statement; Articlo flags it if author input is still needed.
  • You should declare only the acquired funds and grants that are directly relevant to the work reported in your article; for example, This work was supported by the [Funding Agency #1] under Grant [number xxxx]; [Funding Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under Grant [number xxxx].

Competing interests

  • Include or confirm the competing interests required by the journal. Articlo checks this item and flags anything that still needs author input.

Data availability statement

  • Add or confirm the author-written Data availability statement; Articlo flags it if author input is still needed.
  • A data sharing statement must be included to indicate that all sequence data has been deposited into the appropriate database with accession numbers listed.
Show 3 more
  • Authors are required to provide a data availability statement, detailing where data associated with a paper can be found and how it can be accessed.
  • If data cannot be made open, authors should state why in the data availability statement.
  • Authors are required to cite any data sets referenced in the article and provide a Data Availability Statement.

Ethics statement

  • Add or confirm the author-written Ethics statement; Articlo flags it if author input is still needed.
  • In settings where ethics approval for non-interventional studies (e.g. surveys) is not required, authors must include a statement to explain this.
Show 7 more
  • Authors should familiarise themselves with our policy on participant/patient privacy and informed consent.
  • Include the required ethics approval statement and if applicable an informed consent statement under the heading -- Ethics approval -- as the last section of Materials and methods.
  • All original research papers involving humans, animals, plants, biological material, protected or non-public datasets, collections or sites, must include a written statement in the Methods section, confirming ethical approval has been obtained from the appropriate local ethics committee or Institutional Review Board and that where relevant, informed consent has been obtained.
  • Consent All authors are required to follow the ICMJE requirements and Taylor & Francis Editorial Policies on privacy and informed consent from patients and study participants.
  • Authors must include a statement to confirm that any patient, service user, or participant (or that person’s parent or legal guardian) in any type of qualitative or quantitative research, has given informed consent to participate in the research.
  • Case Report: a clinical case report detailing their medical history, identifiable images or media content, etc), authors must include a statement to confirm that they have obtained written informed consent to publish the details from the affected individual (or their parents/guardians if the participant in not an adult or unable to give informed consent; or next of kin if the participant is deceased).
  • Case Report: For submissions where patients or participants can be potentially identified (e.g.

Cover letter

  • Using Third-Party Material in your Paper You must obtain the necessary permission to reuse third-party material in your article.
  • The use of short extracts of text and some other types of material is usually permitted, on a limited basis, for the purposes of criticism and review without securing formal permission.
Show 1 more
  • If you wish to include any material in your paper for which you do not hold copyright, and which is not covered by this informal agreement, you will need to obtain written permission from the copyright owner prior to submission.

Author contributions

  • Submitting authors should be prepared to submit CRediT roles for themselves and their co-authors (where applicable) as part of the submission process.

Supplementary files

  • Include every cited supplementary file and use matching labels in the manuscript.

Title page and author information

  • Provide the author, affiliation, and correspondence details for the separate title page; Articlo creates the editable companion file.
  • All authors of a manuscript must include their full name and affiliation(s).
Show 2 more
  • One author must be clearly designated as the corresponding author and full contact information provided, including full name, email address, and institutional address (normally displayed in the article PDF and the online article), and phone number.
  • Remaining title page details: All sequence data deposited into the appropriate database with accession numbers must be listed and immediate access granted upon epublication.

Article structure and word limits

  • It should be a maximum width of 525 pixels.
  • These instructions will ensure we have everything required so your paper can move through peer review, production and publication smoothly.
Show 38 more
  • Manuscripts specifically addressing clinical observations and findings are encouraged and should be identified as Clinical as indicated in the article types listed below.
  • Systems data including, novel sequences and expression information must be submitted to the appropriate public database and referenced in the text.
  • Authors must agree to sharing materials within a reasonable amount of time if requested.
  • Data must be released once the manuscript is published on line.
  • Manuscripts specifically addressing clinical observations and findings should be identified as Clinical: Research Communication.
  • Research Article: Manuscripts specifically addressing clinical observations and findings should be identified as Clinical: Research Article.
  • A standardized report of causative and risk factors of infertility with an emphasis of male infertility is required (see details below).
  • These should include adequate and appropriate validation to be considered.
  • Any datasets associated with the paper must publish all experimental controls and make full datasets available where possible.
  • If there are concerns about identifying factors in datasets, these should be discussed with the Editor-in-Chief prior to submission.
  • Please note, this is not required for submission but is encouraged.
  • Alternative gene aliases that are commonly used may also be reported, but should not be used alone in place of the HGNC symbol.
  • Chemical compounds nomenclature The synthesis of all new compounds must be described in detail, and information to verify the identity and purity should be included.
  • Note that, regardless of the file format of the original submission, an editable version of the article must be supplied at the revision stage.
  • For all NIH/Wellcome-funded papers, the grant number(s) must be included in the declaration of interest statement.
  • Clinical Trial: Clinical trials should be registered prospectively – i.e. before participant recruitment.
  • Authors of retrospectively registered trials must be prepared to provide further information to the journal editorial office if requested.
  • Clinical Trial: The clinical trial registry should be publicly accessible (at no charge), open to all prospective registrants, and managed by a not-for-profit organization.
  • All research studies on humans (individuals, samples, or data) must have been performed in accordance with the principles stated in the Declaration of Helsinki.
  • Please include all relevant safety precautions; and cite any accepted standard or code of practice.
  • Your research funder or your institution may require you to publish your article open access.
  • Use our APC finder to view the APC for this journal.
  • Queries Should you have any queries, please visit our Author Services website or contact us here.
  • A declaration must be included within the submission stating: Originality and accuracy of content has been confirmed by the authors.
  • Authors must provide full methodological details and adhere to relevant reporting guidelines where applicable.
  • Authors must retain the original and revised versions which must be shared upon request.
  • The PLSP guidelines for authors must be followed at all times.
  • Include a statement regarding any limitations of the study, e.g., small sample size, limited access to data, limitations of research design, lack of generalizability, etc.
  • Gene and Protein Nomenclature: Gene nomenclature and reporting of sequence variants and phenotypes Standardized gene nomenclature should be used throughout the manuscript.
  • Nomenclature for algae, fungi, plants and animals Standardized nomenclature for organisms should be used throughout the manuscript, which should be in accordance with International Code of Nomenclature for algae, fungi and plants (ICN) and the International Commission on Zoological Nomenclature (ICZN).
  • Nomenclature for allergens Standardized nomenclature for allergenic proteins should be used throughout the manuscript, which should be in accordance with the nomenclature approved by World Health Organization/International Union of Immunological Societies (WHO/IUIS) Allergen Nomenclature Sub-committee.
  • Please use SI units (non-italicized).
  • Clinical Trial: Clinical Trials Registry In order to be published in a Taylor & Francis journal, all clinical trials must have been registered in a public repository, ideally at the beginning of the research process (prior to participant recruitment).
  • The process of obtaining consent to publish should include sharing the article with the individual (or whoever is consenting on their behalf), so that they are fully aware of the content of the article before it is published.
  • Please note that data should only be shared if it is ethically correct to do so, where this does not violate the protection of human subjects, or other valid ethical, privacy, or security concerns.
  • Reviews/ Reviews and Hypotheses should be written with the following elements in the following order.
  • Please do not embed it in the manuscript file but save it as a separate file, labelled GraphicalAbstract1.
  • Image descriptions are typically used by systems such as pronouncing screen readers to make images accessible to people that cannot read or see the object due to a visual disability.

Reporting guidelines

  • Include or confirm the reporting guidelines required by the journal. Articlo checks this item and flags anything that still needs author input.

Preprints and prior publication

  • If you have shared an earlier version of your Author’s Original Manuscript on a preprint server, please be aware that anonymity cannot be guaranteed.

Artificial intelligence disclosure

  • Add or confirm the author-written Artificial intelligence statement; Articlo flags it if author input is still needed.
  • Please include a statement disclosing whether and how generative AI has been used in the research and manuscript preparation process.
Show 6 more
  • Use of AI tools as part of ethical research studies is permitted.
  • A declaration must be included within the submission stating: The name and version number of the AI tool used.
  • Systematic Review: Use of AI tools as part of ethically conducted literature reviews, systematic reviews, meta-analysis and bibliometrics studies is permitted.
  • Use of AI tool assisted plain language summaries (PLS) of authors own work is permitted.
  • Please read our guidance on using AI tools in your research and manuscript preparation to understand scenarios where their use may be permissible, and the required information that must be disclosed.
  • A declaration must be included within the submission stating: Confirmation the authors have checked terms of use for the specific AI tool used, and therefore confirm suitability for publication.

Authorship and originality

  • Preparing Your Paper All authors submitting to medicine, biomedicine, health sciences, allied, and public health journals should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, prepared by the International Committee of Medical Journal Editors (ICMJE).

Article type and manuscript length

  • Main file: title page (see Checklist below for details) as first page of main file; unstructured Abstract of up to 300 words that reads as one paragraph; graphical abstract (optional); keywords (between 4 and 6 keywords); list of abbreviations, if applicable; main text: Introduction; review and synthesis of the field ( note: a brief description of the methods is required if preliminary data in support of the Reviews and Hypotheses is presented ); Discussion.
  • Research Communication/ Clinical: Research Communication should be written with the following elements in the following order: Main file: title page (see Checklist below for details) as first page of main file; unstructured Abstract of up to 300 words that reads as one paragraph stating the rationale, hypothesis, results, conclusions and include a statement regarding any limitations of the study, e.g., small sample size, limited access to data, limitations of research design, lack of generalizability, etc.; graphical abstract (optional); 4 - 6 keywords; list of abbreviations (if applicable); main text: Introduction, Results, Discussion (please note that the Results and Discussion can appear as a single section but also as separate sections); Materials and methods, provide all necessary details to allow replication of the study.
Show 6 more
  • Research Article: Research Articles/ Clinical: Research Articles should be written with the following elements in the following order: Main file: title page (see Checklist below for details) as first page of main file; unstructured Abstract of up to 300 words that reads as one paragraph stating the rationale, hypothesis, results, conclusions, and include a statement regarding any limitations of the study, e.g., small sample size, limited access to data, limitations of research design, lack of generalizability, etc.; graphical abstract (optional); keywords (between 4 and 6 keywords); list of abbreviations (if applicable); main text: Introduction, Results, Discussion (please note that the Results and Discussion can appear as a single section but also as separate sections); Materials and methods, provide all necessary details to allow replication of the study.
  • Molecular Diagnostics should be written with the following elements in the following order: Main file: title page (see Checklist below for details) as first page of main file; unstructured Abstract of up to 300 words that reads as one paragraph stating the rationale, hypothesis, results, conclusions, and include a statement regarding any limitations of the study, e.g., small sample size, limited access to data, limitations of research design, lack of generalizability, etc.; graphical abstract (optional), keywords (between 4 and 6 keywords), list of abbreviations (if applicable), main text: Introduction, Results, Discussion (please note that the Results and Discussion can appear as a single section but also as separate sections); Materials and methods, provide all necessary details to allow replication of the study.
  • Section headings for the Introduction, Results and Discussion, Materials and methods are not required ( include the required Ethics approval statement and informed consent statement as the last section of the main text under the heading -- Ethics approval ); Followed by: Acknowledgments (if applicable), Funding (see below), Declaration of interests, References (in journal format, see References below), figure captions (as a list) with figure titles in bold and figure panel identification, if applicable, using upper case letters.
  • Application Notes/ Clinical: Application Notes should be written with the following elements in the following order: Main file: title page (see Checklist below for details) as first page of main file; unstructured Abstract of up to 300 words that reads as one paragraph stating the rationale, hypothesis, results, conclusions, and include a statement regarding any limitations of the study, e.g., small sample size, limited access to data, limitations of research design, lack of generalizability, etc.; graphical abstract (optional), keywords (between 4 and 6 keywords), list of abbreviations (if applicable); main text: Introduction; does not require section headings for Results and Discussion and Materials and methods, option to combine the Results and Discussion and the Materials and methods into a single section or as separate sections ( include the required Ethics approval statement and if applicable an informed consent statement as the last section of the main text under the heading -- Ethics approval ).
  • Should be written with the following elements in the following order: title page (see checklist below for details), unstructured abstract (see below), including a statement of limitations, a list of 4 – 6 keywords, and a list of abbreviations; main text in the following order: Introduction, Results, Discussion, Methods or Materials and methods with Ethics approval statement at the end of this section (include an informed consent statement if applicable); followed by Acknowledgments, Funding, Declaration of interest statement, Data sharing statement (indicate, when applicable, that all sequence data has been deposited into the appropriate database with accession numbers listed), References, and figure captions, with titles in bold submitted separate from figures as a list placed after the references; Supplementary material (as appropriate).
  • Title page: The title page should include the requested Article Type (listed above) and clinical designation when appropriate, followed by the article title of up to 130 characters including spaces, and the following.

Manuscript structure

  • All manuscripts must include a discussion of the known biochemical or clinical basis.
  • Authors must retain full records of the methods undertaken, including full descriptions and records of the prompts used, which must be shared with the journal upon request.
Show 1 more
  • Clinical Trial: However, for clinical trials that have not been registered prospectively, Taylor & Francis journals requires retrospective registration to ensure the transparent and complete dissemination of all clinical trial results which ultimately impact human health.

Language and text style

  • Nomenclature and abbreviations should follow the recommendations from the International Union of Pure and Applied Chemistry (IUPAC).

Study reporting guidelines

  • For animal studies, approval must have been obtained from the local or institutional animal use and care committee.
  • Authors must provide full methodological details and adhere to relevant reporting guidelines where applicable (e.g. CONSORT-AI, STARD-AI, GAMER, TRIPOD-AI, etc).
Save journal and get updates Download complete checklist

What your package checks

Abstract: 300 words
Keywords: 4-6 keywords
Title page: separate file
Declarations: Data availability, Funding, Ethics, Artificial intelligence

Source transparency

This preparation guide uses published journal-specific author requirements. Journal instructions can change, so authors should complete a final review before submission.

Open official guideline source